A clinical-stage biopharmaceutical company focused on therapies for serious hematologic diseases, including rare heme biosynthesis disorders and disorders of iron homeostasis. Its pipeline is built around biologic control points that regulate hemoglobin and iron availability.
A clinical-stage biopharmaceutical company focused on therapies for serious hematologic diseases, including rare heme biosynthesis disorders and disorders of iron homeostasis. Its pipeline is built around biologic control points that regulate hemoglobin and iron availability.
